COMMUNIQUÉ RÉGLEMENTÉ
News
-
-
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: Biotest AG: Change of the Chief Executive Officer (CEO) of Biotest AG
Biotest AG announces change of CEO. Dr. Jörg Schüttrumpf appointed new CEO, succeeding Peter Janssen by mutual agreement. Supervisory Board thanks Mr. Janssen for his past commitment. Dr. Schüttrumpf previously served on the Management Board -
COMMUNIQUÉ DE PRESSE
Leifheit AG: Annual General Meeting approves increased total dividend of EUR 1.20 per dividend-entitled share
Leifheit AG's Annual General Meeting approves increased total dividend of EUR 1.20 per dividend-entitled share. New corporate strategy for growth and profitability presented -
-
COMMUNIQUÉ DE PRESSE
EQS-Adhoc: FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek
FamiCord AG acquires majority stake in Národní Centrum Pupečníkové Krve and Rodinná banka perinatálnych a mezenchymálnych buniek from Primecell Advanced Therapy, expanding its stem cell bank services in Europe -
COMMUNIQUÉ DE PRESSE
Key Consolidated Results as of December 31, 2024
-
-
-
